Dominant biological processes $ | E-2 h | E-6 h | &C-E2h | C-E6h | H-E2h | H-E6h | S-E2h | S-E6h | AM- E6h | important DEGs* |
---|---|---|---|---|---|---|---|---|---|---|
androgen receptor signalling | x | ITGAV, YWHAH, CSNK2B, CTNNB1, ITGB5 | ||||||||
angiogenesis (blood vessel growth) | x | x | x | x | x | HMOX1, FLT1, THBS1, ITGB3, CCL2, NRP2,ITGA6, ITGAV, PTGS2 | ||||
antigen recognition | x | x | x | x | x | NFKBIE, CXCL2, BCL10, IL1A, FOS, TNFAIP3, BIRC3, NFKBIA, CXCL8 | ||||
apoptosis | x | x | x | x | x | x | SPTLC1, ITGB3, THBS1, DDIT4, YWHAH | |||
cell motility | x | x | x | x | x | ITGB3, ANXA1, ITGA6, ITGAV, TPM1, TPM4 | ||||
cytoskeleton | x | x | SOS2, PFN2, ARPC1A, ARPC1B, PSEN2, ARPC4, RTN4, ITGB3 | |||||||
extra cellular matrix structure | x | x | x | x | x | x | CUL1, YWHAH, BTRC/Collagens (COL), SPARC | |||
glycogenesis/glycan synthesis | x | x | x | MUC13, MUC4, HSPG2, PCK2 | ||||||
hormone processes (Thyroid) | x | IGF1R, ITGB3, ITGAV | ||||||||
immune modulation | x | x | x | x | x | cytokines, TGF, chemokines | ||||
inflammation | x | x | x | x | x | HBEGF, CSF2, CXCL2, IL1A, BIRC3, MMP9, CCL20, LTB, BTRC, HSPB2 | ||||
neutrophil function (innate immune cells) | x | x | SOS2, LTBP4, MAPK14, FLT1, IGF1R, PDGFA, ACE, EGFR, DDIT4, FGFR1, TGFA, BMP1, CCL2, RPS6, NRP2 | |||||||
NFKB immune signalling | x | x | x | PTGS2, NFKBIA, CXCL8, TNFAIP3, BTRC | ||||||
oxidative stress | x | x | x | x | HMOX1, NQO1, EGLN3 | |||||
Transforming Growth Factor | x | x | CUL1, THBS1, BTRC, ITGB3 | |||||||
translation (protein synthesis) | x | x | x | x | x | x | x | EEF1A1, HSP90B1, DDIT3 | ||
tumour necrosis factor (inflammation) | x | x | x | JAG1, MAPK14, CSF2, CXCL2, TNFAIP3, BIRC3, CASP10, CCL20, CCL2, NFKBIA |